Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

Webinar | Berkheimer v. HP: A Favorable Shift for Software and Medical Methodology Patents?

Thursday, July 19th, 2018, 1:00 pm EDT

Webinar | Berkheimer v. HP: A Favorable Shift for Software and Medical Methodology Patents?

This webinar took place on: Thursday, July 19th, 2018, 1:00 pm EDT

This webinar has ended.
Back to Webinars Listing

The Federal Circuit’s recent decision in Berkheimer v. HP Inc., 881 F.3d 1360 (Fed. Cir 2018) provided important new guidance outlining additional proof requirements to invalidate software and medical methodology patents in court for lack of patent-eligible subject matter (often referred to as Alice motions or Alice rejections). Now, the new USPTO director has extended the Berkheimer decision to patent examination–establishing new guidelines for examiners at the USPTO to follow, which are considered by many to represent a significant shift in USPTO policy favorable to patent applicants.

Please join us as Rob Courtney and Michael Hawkins discuss this recent Federal Circuit decision and how this shift will affect patent applicants.

Thursday, July 19, 2018
1:00 – 2:00 PM ET

Fish & Richardson will apply for 1.0 hour of general CLE credit in most states. If you would like to receive CLE credit, register with your state bar information. Please note that you must be logged in to the webinar on your device in order to request CLE credit. CLE credit will not be granted for listening to the audio portion only.

If you have questions, please contact Jane Lundberg at lundberg@fr.com.